SCHEMBL7852252

SCHEMBL7852252

CC(C)(C)OC(=O)N[C@@](CC1CCCCC1)(C(=O)OC(c1ccccc1)c1ccccc1)C(=O)[C@@H](N)CC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 1/20 0.36
CTSS P25774 2/20 0.35
CTSK P43235 2/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
CACNA1B Q00975 1/20 0.34
REN P00797 6/20 0.33
AAK1 Q2M2I8 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
METAP2 P50579 1/20 0.33
METAP1 P53582 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA7 P43166 1/20 0.33
CA14 Q9ULX7 1/20 0.33
GUCY1B2 O75343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7204626 0.93 OPRK1 (0.36) OPRK1CTSSCTSKFNTAFNTB
SCHEMBL7210238 0.86 OPRK1 (0.36) OPRK1CTSSCTSKFNTAFNTB
SCHEMBL7212756 0.80 KLK7 (0.36) OPRK1CTSSCTSKFNTAFNTB
SCHEMBL7205002 0.78 FNTA (0.38) OPRK1FNTAFNTBMMP1MMP2
SCHEMBL7205034 0.74 FNTA (0.37) OPRK1FNTAFNTBMMP1MMP2
SCHEMBL7858173 0.73 TSHR (0.34) KMT2AL3MBTL1METAP2
SCHEMBL7852245 0.70 CTSS (0.52) CTSSCTSKMMP1MMP2MMP3
SCHEMBL7852248 0.70 MMP1 (0.37) OPRK1CTSSCTSKMMP1MMP2
SCHEMBL7204995 0.68 MMP2 (0.50) CTSSCTSKMMP1MMP2MMP3
SCHEMBL7205030 0.68 MMP2 (0.48) MMP1MMP2MMP3METAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180759-B1 PREPARING AZACYCLOALKANOYLPSEUDOTETRAPEPTIDES COMPRISING COUPLING A DIPEPTIDE WITH A PSEUDODIPEPTIDE; FOR EXAMPLE, N-(N-ETHYL-N-(1-OXO-4-(4-PIPERIDINYL)BUTYL)GLYCYL)-(L)-ALPHA-ASPARTYL-3 -CYCLOHEXYL-(L)-ALANINEAMIDE; USE AS ANTICOAGULANTS AVENTIS PHARMACEUTICALS PRODUCTS INC. 2001-01-30 US disclosed